Showing results (2011-2020 of 2,443) with videos related to
Sort By:
Pageof 245
The Journal of General Virology|July 1, 2011
Interspecies transmission of the canine influenza H3N2 virus to domestic cats in South Korea, 2010D S Song, D J An, H J Moon, et al.Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|April 9, 2026
[Impact of anti-gp210 and anti-centromere antibody dual positivity on clinical prognosis in patients with primary biliary cholangitis: risk analysis and establishment of response criteria]J Luo, D W Ding, G Y Guo, et al.Nature Communications|April 21, 2026
Cell fate specification during respiratory development requires ARID1A-containing canonical BAF complex activityHyunwook Lee, Abigail Jaquish, Sharlene Fernandes, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 16, 2022
Essential elements of optimal dietary and exercise referral practices for cancer survivors: expert consensus for medical and nursing health professionalsRia Joseph, Nicolas H Hart, Natalie Bradford, et al.International Journal of Cancer|December 6, 2008
Functional significance of VEGFR-2 on ovarian cancer cellsWhitney A Spannuth, Alpa M Nick, Nicholas B Jennings, et al.Journal of the National Cancer Institute|March 4, 2008
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growthWilliam M Merritt, Yvonne G Lin, Whitney A Spannuth, et al.Folia Morphologica|April 6, 2019
The applied anatomy and clinical significance of the proximal, V1 segment of vertebral arteryX Li, L Guan, Prince L M Zilundu, et al.Molecular Psychiatry|April 26, 2017
Uncoupling DAPK1 from NMDA receptor GluN2B subunit exerts rapid antidepressant-like effectsS-X Li, Y Han, L-Z Xu, et al.Cancer Biology & Therapy|September 10, 2009
Anti-angiogenic properties of metronomic topotecan in ovarian carcinomaWilliam M Merritt, Christopher G Danes, Mian M K Shahzad, et al.Oncogene|April 21, 2001
Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphomaS H Lee, M S Shin, H S Kim, et al.Pageof 245